Cargando…

Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic Studies

The fact that cerebrospinal fluid (CSF) deeply irrigates the brain together with the relative simplicity of sample extraction from patients make this biological fluid the best target for biomarker discovery in neurodegenerative diseases. During the last decade, biomarker discovery has been especiall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedrero-Prieto, Cristina M., Frontiñán-Rubio, Javier, Alcaín, Francisco J., Durán-Prado, Mario, Peinado, Juan R., Rabanal-Ruiz, Yoana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467255/ https://www.ncbi.nlm.nih.gov/pubmed/34573996 http://dx.doi.org/10.3390/diagnostics11091655

Ejemplares similares

The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
por: Frontiñán-Rubio, Javier, et al.
Publicado: (2021)

A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease
por: Pedrero-Prieto, Cristina M., et al.
Publicado: (2020)

Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease
por: Llanos-González, Emilio, et al.
Publicado: (2020)

Spatial and Temporal Protein Modules Signatures Associated with Alzheimer Disease in 3xTg-AD Mice Are Restored by Early Ubiquinol Supplementation
por: Llanos-González, Emilio, et al.
Publicado: (2023)

Ubiquinol Supplementation Improves Gender-Dependent Cerebral Vasoreactivity and Ameliorates Chronic Inflammation and Endothelial Dysfunction in Patients with Mild Cognitive Impairment
por: García-Carpintero, Sonia, et al.
Publicado: (2021)

Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization
por: Pedrero-Prieto, Cristina M., et al.
Publicado: (2019)

CoQ(10) reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation
por: Frontiñán-Rubio, Javier, et al.
Publicado: (2022)

The Use of Coenzyme Q10 in Cardiovascular Diseases
por: Rabanal-Ruiz, Yoana, et al.
Publicado: (2021)

Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation
por: Frontiñán-Rubio, Javier, et al.
Publicado: (2023)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
por: Tijms, Betty M, et al.
Publicado: (2020)

Quantitative proteomics of delirium cerebrospinal fluid
por: Poljak, A, et al.
Publicado: (2014)

Coenzyme Q(10) Protects Human Endothelial Cells from β-Amyloid Uptake and Oxidative Stress-Induced Injury
por: Durán-Prado, Mario, et al.
Publicado: (2014)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
por: Bader, Jakob M, et al.
Publicado: (2020)

Establishing the Proteome of Normal Human Cerebrospinal Fluid
por: Schutzer, Steven E., et al.
Publicado: (2010)

Proteomics Study on the Cerebrospinal Fluid of Patients with Encephalitis
por: Xiong, Liu-Lin, et al.
Publicado: (2021)

Rapid and efficient testing of the toxicity of graphene-related materials in primary human lung cells
por: Frontiñan-Rubio, Javier, et al.
Publicado: (2022)

Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
por: Wildsmith, Kristin R, et al.
Publicado: (2014)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Identification and proteomic profiling of exosomes in human cerebrospinal fluid
por: Street, Jonathan M, et al.
Publicado: (2012)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
por: Gómez-Baena, Guadalupe, et al.
Publicado: (2017)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia
por: Chen, Kai, et al.
Publicado: (2023)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
por: Konijnenberg, Elles, et al.
Publicado: (2020)

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
por: Mroczek, Magdalena, et al.
Publicado: (2022)

Identification of Candidate Biomarkers of Alzheimer’s Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics
por: Liu, Ping, et al.
Publicado: (2023)

Sublethal exposure of small few-layer graphene promotes metabolic alterations in human skin cells
por: Frontiñan-Rubio, Javier, et al.
Publicado: (2020)

Subchronic Graphene Exposure Reshapes Skin Cell Metabolism
por: Frontiñan-Rubio, Javier, et al.
Publicado: (2022)

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
por: Bai, Shumei, et al.
Publicado: (2009)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease
por: Rotunno, Melissa S., et al.
Publicado: (2020)

The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome
por: Leifsdottir, Kristin, et al.
Publicado: (2022)

Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis
por: Chen, Juncao, et al.
Publicado: (2022)

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
por: Isgren, Anniella, et al.
Publicado: (2022)

Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
por: Kangas, Petra, et al.
Publicado: (2023)

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020)

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
por: d’Abramo, Cristina, et al.
Publicado: (2020)

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1rek5b0t0fl7u7k0t9h0bcm670